REFERENCES
- Singh B., Copolov D., Grainger D., Goh J. Partnerships between academic psychiatry and the pharmaceutical industry. The Lilly MAP Initiative. Australasian Psychia try 2004; 12: 220–224
- Emanuel E. J., Wendler D., Grady C. What makes clini cal research ethical?. Journal of the American Medical Association 2000; 283: 2701–2711
- Dana J., Loewenstein G. A social science perspec tive on gifts to physicians from industry. Journal of the American Medical Association 2003; 290: 252–255
- Katz D., Caplan A. L., Merz J. F. All gifts large and small: toward an understanding of theethics of pharmaceutical industry. gift-giving. American Journal of Bioethics 2003; 3: 39–46
- Malhi G. Comment. Australasian Psychiatry 2004; 12: 225–226
- Financial disclosure for review authors. Nature Neuro- science 2003; 6: 997
- Carroll B. J., Bubin B. T. Editorial policies on financial disclosure. Nature Neuroscience 2003; 6: 999–1000
- Lexchin J., Bero L. A., Djulbegovic B., Clark O. . Phar maceutical industry sponsorship and research outcome and quality: systematic review. British Medical Journal 2003; 326: 1167–1170
- Melander H., Ahlqvist-Bastad J., Meijer G., Beerman B. Evidence based medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003; 326: 1171–1173
- Bhandari M., Busse J. W., Jackowski D., et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Canadian MedicalAssociation Journal 2004; 170: 477–480
- Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. Journal of the American Medical Association 2000; 283: 373–380
- Relman A. S., Angell M. America's other drug problem: how the drug industry distorts medicine and politics. New Republic mi, 2002; 227: 27–41
- Lilly Melbourne Academic Psychiatry. Department of Psychiatry, University of Mel bourne, Melbourne, http://www.psychiatry.unimelb.edu.au/lillymap/Pages/Lilly%20MAP%20overview.htm
- Hicks D., Hamilton K. . Does university-industry col laboration adversely affect university research?. Is sues in Science and Technology 1999; 74–75, www. issues.org/15.4/realnumbers.htm
- Access Economics. Exceptional Returns: the Value of Investing in Health R&D in Australia. Australian Society for Medical Research, Canberra 2003, www. asmr.org.au/general/Except.pdf
- Singh B. Academic departments of psychiatry in Aus tralia: a need for reinvention. Australasian Psychiatry 2002; 10: 147–154
- DiMasi J. A., Hansen B. W., Grabowski H. G. The price of innovation: new estimates of drug development costs. Journal of Health Economics 2003; 22: 151– 185